Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIIA Stage Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02977169
What this trial is testing

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 300
Early research (Phase 1)Study completedNCT00016315
What this trial is testing

Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 35
Early research (Phase 1)Active Not RecruitingNCT04505267
What this trial is testing

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00334815
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Large Cell Carcinoma+4 more
National Cancer Institute (NCI) 29
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT00022243
What this trial is testing

T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
Tularik
Testing effectiveness (Phase 2)Looking for participantsNCT07492342
What this trial is testing

Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC

Who this might be right for
Resectable NSCLCKRAS G12C MutationStage IB-IIIA NSCLC+1 more
Jianxing He 30
Not applicableLooking for participantsNCT05802186
What this trial is testing

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Who this might be right for
Lung CarcinomaLung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the Lung+3 more
Northwestern University 70
Early research (Phase 1)Study completedNCT02947386
What this trial is testing

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
EGFR Gene MutationRecurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung Cancer+2 more
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT00004151
What this trial is testing

Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Testing effectiveness (Phase 2)Study completedNCT00005850
What this trial is testing

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Anxiety DisorderDepressionFatigue+1 more
Alliance for Clinical Trials in Oncology 21
Testing effectiveness (Phase 2)UnknownNCT05005468
What this trial is testing

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Who this might be right for
NSCLC
Shanghai Chest Hospital 61
Testing effectiveness (Phase 2)Study completedNCT00002642
What this trial is testing

SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 116
Large-scale testing (Phase 3)UnknownNCT04840290
What this trial is testing

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 30
Not applicableUnknownNCT03509779
What this trial is testing

Pronostic and Predictive Value of EMT in Localized Lung Cancer

Who this might be right for
NSCLC, Stage I, II, IIIA, IIIBSurgeryProgression+1 more
European Georges Pompidou Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00005093
What this trial is testing

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Pfizer
Testing effectiveness (Phase 2)UnknownNCT02036359
What this trial is testing

Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
National Taiwan University Hospital 76
Testing effectiveness (Phase 2)WithdrawnNCT01533727
What this trial is testing

CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University
Early research (Phase 1)Ended earlyNCT00866086
What this trial is testing

Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 10
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Next Page